BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/25/2020 9:57:11 AM | Browse: 753 | Download: 1364
 |
Received |
|
2020-01-20 10:39 |
|
Peer-Review Started |
|
2020-01-20 10:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-03-18 18:48 |
|
Revised |
|
2020-03-19 12:10 |
|
Second Decision |
|
2020-04-14 13:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-04-14 23:40 |
|
Articles in Press |
|
2020-04-14 23:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-04-22 02:27 |
|
Typeset the Manuscript |
|
2020-05-13 01:36 |
|
Publish the Manuscript Online |
|
2020-05-25 09:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Retrospective Study |
| Article Title |
Ligliptin in the treatment of type 2 diabetes mellitus with early renal injury and its effect on endogenous hydrogen sulfide and endothelial function
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian Zhang, Yong-Li Du, Hui Zhang, Hong Sui and Wei-Kai Hou |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Kai Hou, PhD, Chief Physician, Professor, Department of Endocrinology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan 250012, Shandong Province, China. pro.hwk@163.com |
| Key Words |
Ligliptin; Type 2 diabetes; Early renal injury; Serum endogenous hydrogen sulfide; Endothelial cell granules; Endothelial function |
| Core Tip |
At present, diabetes is believed to accelerate the process of atherosclerosis in patients, and abnormal endothelial function is an important factor leading to diabetic kidney damage. The dipeptidyl peptidase 4 inhibitor drug litagliptin belongs to intestinal insulinotropic drugs, which can effectively reduce blood sugar. In order to further confirm the effect and specific mechanism of ligliptin application in patients with type 2 diabetes with kidney injury, this study observed the effect of two drugs. |
| Publish Date |
2020-05-25 09:57 |
| Citation |
Zhang J, Du YL, Zhang H, Sui H, Hou WK. Ligliptin in the treatment of type 2 diabetes mellitus with early renal injury and its effect on endogenous hydrogen sulfide and endothelial function. World J Clin Cases 2020; 8(10): 1878-1886 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i10/1878.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i10.1878 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
